These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24324895)

  • 1. Impact of pretransplant hepatic encephalopathy on liver posttransplantation outcomes.
    Teperman LW
    Int J Hepatol; 2013; 2013():952828. PubMed ID: 24324895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Considerations on the impact of hepatic encephalopathy treatments in the pretransplant setting.
    Teperman LW; Peyregne VP
    Transplantation; 2010 Apr; 89(7):771-8. PubMed ID: 20110852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation significantly improves global functioning and cerebral processing.
    Ahluwalia V; Wade JB; White MB; Gilles HS; Heuman DM; Fuchs M; Gavis EA; Fagan A; Tinsley F; Ganapathy D; Thacker LR; Sterling RK; Stravitz RT; Puri P; Sanyal AJ; Siddiqui MS; Matherly S; Luketic V; Steinberg J; Moeller FG; Bajaj JS
    Liver Transpl; 2016 Oct; 22(10):1379-90. PubMed ID: 27339647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis.
    Prakash RK; Kanna S; Mullen KD
    Clin Ther; 2013 Sep; 35(9):1458-73. PubMed ID: 23972578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on management of patients with overt hepatic encephalopathy.
    Chacko KR; Sigal SH
    Hosp Pract (1995); 2013 Aug; 41(3):48-59. PubMed ID: 23948621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy for hepatic encephalopathy.
    Phongsamran PV; Kim JW; Cupo Abbott J; Rosenblatt A
    Drugs; 2010 Jun; 70(9):1131-48. PubMed ID: 20518580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of hepatic encephalopathy in the hospital.
    Leise MD; Poterucha JJ; Kamath PS; Kim WR
    Mayo Clin Proc; 2014 Feb; 89(2):241-53. PubMed ID: 24411831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant.
    Tchervenkov JI; Tector AJ; Barkun JS; Sherker A; Forbes CD; Elias N; Cantarovich M; Cleland P; Metrakos P; Meakins JL
    Ann Surg; 1997 Sep; 226(3):356-65; discussion 365-8. PubMed ID: 9339942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifaximin for treatment of hepatic encephalopathy.
    Maclayton DO; Eaton-Maxwell A
    Ann Pharmacother; 2009 Jan; 43(1):77-84. PubMed ID: 19092143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations for the cost-effective management of hepatic encephalopathy.
    Flamm SL
    Am J Manag Care; 2018 Mar; 24(4 Suppl):S51-S61. PubMed ID: 29521513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of overt hepatic encephalopathy.
    Sharma P; Sharma BC
    J Clin Exp Hepatol; 2015 Mar; 5(Suppl 1):S82-7. PubMed ID: 26041964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disaccharides in the treatment of hepatic encephalopathy.
    Sharma P; Sharma BC
    Metab Brain Dis; 2013 Jun; 28(2):313-20. PubMed ID: 23456517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifaximin for the treatment of hepatic encephalopathy.
    Mullen K; Prakash R
    Expert Rev Gastroenterol Hepatol; 2010 Dec; 4(6):665-77. PubMed ID: 21108586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy of hepatic encephalopathy in cirrhosis.
    Romero-Gómez M
    Expert Opin Pharmacother; 2010 Jun; 11(8):1317-27. PubMed ID: 20384539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifaximin treatment for reduction of risk of overt hepatic encephalopathy recurrence.
    Flamm SL
    Therap Adv Gastroenterol; 2011 May; 4(3):199-206. PubMed ID: 21694804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Hepatic Encephalopathy: A Primer.
    Jawaro T; Yang A; Dixit D; Bridgeman MB
    Ann Pharmacother; 2016 Jul; 50(7):569-77. PubMed ID: 27126547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, neuropsychological and neurophysiological indices and predictors of hepatic encephalopathy (HE).
    Formentin C; Zarantonello L; Mangini C; Frigo AC; Montagnese S; Merkel C
    Liver Int; 2021 May; 41(5):1070-1082. PubMed ID: 33411388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantation.
    Sotil EU; Gottstein J; Ayala E; Randolph C; Blei AT
    Liver Transpl; 2009 Feb; 15(2):184-92. PubMed ID: 19177446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation and Management of Hepatic Encephalopathy: Current Status and Future Directions.
    Suraweera D; Sundaram V; Saab S
    Gut Liver; 2016 Jul; 10(4):509-19. PubMed ID: 27377741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the impact of rehospitalization in the management of hepatic encephalopathy.
    Saab S
    Int J Gen Med; 2015; 8():165-73. PubMed ID: 25999756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.